HYFTOR ® is for patients 6 years of age and older who have facial angiofibroma—one of the most visible signs of TSC. Ask your doctor if HYFTOR ® is right for you and when it will be available to help you treat your facial angiofibroma.

HYFTOR ® is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex (TSC) in adults and pediatric patients 6 years of age and older. Facial angiofibroma is one of the most visible manifestations of TSC. 1,2

HYFTOR ® is a prescription medicine that is used on the skin (topical) to treat adults and children 6 years of age and older with a type of noncancerous tumor called angiofibroma on your face caused by the genetic condition tuberous sclerosis. It is not known if HYFTOR ® is safe and effective in children under 6 years of age.

HYFTOR ® is a prescription medicine that is used on the skin (topical) to treat adults and children 6 years of age and older with a type of noncancerous tumor called angiofibroma on your face caused by the genetic condition tuberous sclerosis.

HYFTOR is an mTOR inhibitor immunosuppressant indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older.

HYFTOR ® is the first and only topical medication approved by the FDA to treat facial angiofibroma associated with tuberous sclerosis complex (TSC) in adults and children 6 years and older. HYFTOR ® is a clear gel that contains an mTOR inhibitor.

HYFTOR ® is a prescription medicine that is used on the skin (topical) to treat adults and children 6 years of age and older with a type of noncancerous tumor called angiofibroma on your face caused by the genetic condition tuberous sclerosis. It is not known if HYFTOR ® is safe and effective in children under 6 years of age.

HYFTOR ® (sirolimus topical gel) 0.2% is commercially available in the U.S. by prescription as the first topical treatment indicated for facial angiofibroma associated with tuberous sclerosis complex in adults and children 6 years of age or older.

HYFTOR ® is an mTOR inhibitor immunosuppressant indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older. Important Safety Information

HYFTOR ® is a prescription medicine that is used on the skin (topical) to treat adults and children 6 years of age and older with a type of noncancerous tumor called angiofibroma on your face caused by the genetic condition tuberous sclerosis. It is not known if HYFTOR ® is safe and effective in children under 6 years of age.